ALVO stock icon

Alvotech
ALVO

$12.15
2.02%
 

About: Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Employees: 999

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 3 analysts
0
News positive %
of 12 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

122% more call options, than puts

Call options by funds: $1.22M | Put options by funds: $0

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

22% more funds holding

Funds holding: 18 [Q4 2023] → 22 (+4) [Q1 2024]

1.18% less ownership

Funds ownership: 6.52% [Q4 2023] → 5.34% (-1.18%) [Q1 2024]

12% less capital invested

Capital invested by funds: $197M [Q4 2023] → $172M (-$24.4M) [Q1 2024]

25% less funds holding in top 10

Funds holding in top 10: 4 [Q4 2023] → 3 (-1) [Q1 2024]

Research analyst outlook

3 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$17
40%
upside
Avg. target
$19.67
62%
upside
High target
$22
81%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Barclays
Balaji Prasad
81%upside
$22
Overweight
Maintained
24 May 2024
Barclays
Balaji Prasad
65%upside
$20
Overweight
Maintained
22 Mar 2024
Barclays
Balaji Prasad
40%upside
$17
Overweight
Upgraded
29 Jan 2024

Financial journalist opinion

Based on 12 articles about ALVO published over the past 30 days